Wang Man, Liu Rongrong, Liang Yuzhen, Yang Gaohui, Huang Yumei, Yu Chunlan, Sun Kaiqi, Lai Yongrong, Xia Yang
Department of Hematology, First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, China.
Department of Endocrinology, First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, China.
United European Gastroenterol J. 2017 Feb;5(1):94-103. doi: 10.1177/2050640616646525. Epub 2016 Jun 23.
Early detection of liver fibrosis in thalassemia patients and rapid initiation of treatment to interfere with its progression are extremely important.
This study aimed to find a sensitive, easy-to-detect and noninvasive method other than liver biopsy for early detection of liver fibrosis in thalassemia patients.
A total of 244 Chinese Thalassemia patients with non-transfusion-dependent thalassemia (NTDT, = 105) or thalassemia major (TM, = 139) and 120 healthy individuals were recruited into the present study, and blood collagen type IV (C IV), precollagen type III (PIIINPC) and hyaluronic acid (HA), aspartate aminotransferase (AST), alanine aminotransferase (ALT) and ferritin were measured. Liver iron concentration was determined by MRI. The correlation of serum markers with liver iron load and liver function was evaluated.
Serum C IV, PIIINPC and HA were significantly elevated in Chinese patients with NTDT and further elevated in TM patients. Moreover, C IV, PIIINPC and HA were also positively correlated to serum ferritin and liver iron concentration and further elevated during the progression to multi-organ damage in NTDT patients. Finally, serum ferritin and liver iron concentration were significantly correlated with liver dysfunction determined by AST and ALT.
Taken together, our results indicate that monitoring serum C IV, PIIINPC and HA is a potentially sensitive method to predict the risks for iron overload-related liver fibrosis in Chinese thalassemia patients.
地中海贫血患者肝纤维化的早期检测以及迅速开始治疗以干预其进展极为重要。
本研究旨在寻找一种除肝活检之外的敏感、易于检测且无创的方法,用于早期检测地中海贫血患者的肝纤维化。
本研究共纳入244例中国地中海贫血患者,其中非输血依赖型地中海贫血(NTDT,n = 105)或重型地中海贫血(TM,n = 139),以及120名健康个体,检测血液中的IV型胶原(C IV)、III型前胶原(PIIINPC)、透明质酸(HA)、天冬氨酸转氨酶(AST)、丙氨酸转氨酶(ALT)和铁蛋白。通过MRI测定肝脏铁浓度。评估血清标志物与肝脏铁负荷和肝功能的相关性。
中国NTDT患者血清C IV、PIIINPC和HA显著升高,TM患者进一步升高。此外,C IV、PIIINPC和HA也与血清铁蛋白和肝脏铁浓度呈正相关,且在NTDT患者进展为多器官损害时进一步升高。最后,血清铁蛋白和肝脏铁浓度与由AST和ALT测定的肝功能障碍显著相关。
综上所述,我们的结果表明,监测血清C IV、PIIINPC和HA是预测中国地中海贫血患者铁过载相关肝纤维化风险的一种潜在敏感方法。